Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
about
Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcineEffects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placementRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsFludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activationComputational simulation methodologies for mechanobiological modelling: a cell-centred approach to neointima development in stentsAffinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.A novel mouse model of in-stent restenosisDrug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation.Healing the injured vessel wall using microRNA-facilitated gene delivery.A comparative anatomic and physiologic overview of the porcine heart.In vitro evaluation of cenderitide-eluting stent I -an antirestenosis and proendothelization approach.The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.An entropic perspective of protein stability on surfacesComplex porcine model of atherosclerosis: induction of early coronary lesions after long-term hyperlipidemia without sustained hyperglycemia.Development of a rabbit model for a preclinical comparison of coronary stent types in-vivo.A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.Factors that affect mass transport from drug eluting stents into the artery wall.Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents.Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds.Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model.Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.Quantitative assessment of the stent/scaffold strut embedment analysis by optical coherence tomography.Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury.A histopathological comparison of different definitions for quantifying in-stent neointimal tissue: implications for the validity of intracoronary ultrasound and optical coherence tomography measurements.Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.Translation in cardiovascular stents and occluders: From biostable to fully degradable.Neoatherosclerosis and Late Thrombosis After Percutaneous Coronary Intervention: Translational Cardiology and Comparative Medicine from Bench to Bedside.
P2860
Q28212482-01524D6F-5E82-48E0-81C1-672476F35B73Q28476506-B1877748-74B1-4372-8A81-87AAD238EDEBQ28482627-D734DC63-E968-4E1C-AD97-C5D156469955Q28576748-B8117027-9973-460C-81E6-FF75EE6A754FQ30496703-E6D9A412-FB51-45FA-AAC2-9CD9152178CBQ33314508-C33529E3-D95B-4768-B5B4-FE3FEBEF5C03Q33755946-1507B8DE-43F2-46E8-AE7C-93C21E3F2A74Q34109253-41BC3B88-F899-48A2-B6E8-282785994E45Q34117575-0C323FB8-DE71-4424-84DE-BC3E113D2D6DQ34274290-1F662EB6-ADF0-4146-AF20-53F9B9AD546AQ36206241-C2644F07-66C7-43B4-8BAC-46A085233E25Q36405134-AC5366BD-155B-435D-85E2-6DCACF78AD7FQ36470750-C7056F7A-8037-459A-8167-84FFE1052B47Q36785231-29C04B54-4915-4654-B6B2-77FEFFC2E87BQ37252884-F4C52312-F098-47E9-93AC-9205D51DC0BDQ37399608-64673DA2-0A57-4A25-BE50-09FBB350812CQ37404318-3A1B783D-7A7B-46EB-882E-89BC09746857Q37705587-9E7A3908-BAB3-46C4-90FF-BADB6E5FF75DQ38254621-292B8F0C-7848-4A98-A6F5-9407D3CF138DQ38862444-3BDA1255-21D5-46E2-B002-C0E92620A238Q40693886-082FE75E-A7AC-4C4B-B0CE-7EC0F3F657CEQ41390902-3335A61B-928D-46EC-B25D-E8A1A4BF0BFAQ42000738-978AC08F-D299-4CB4-9E04-2309F9DA4FC8Q42008887-F8FF181B-BCAB-481C-AB56-BFAB7B448559Q42679094-9ADB71AD-403B-4310-8334-D490B9C256BBQ42870553-D997DCAB-75B4-4687-906F-0D7332A29FF0Q47655289-6BA00BB3-5B98-4FB9-A699-D530E7174CDFQ48228974-057F7F41-5F91-4C90-B34F-3B82BC841CDDQ52724991-A3CCFBBB-147D-4723-B53E-5EB0BEF7EBDCQ54763757-257BC6EB-D3EF-4B62-8C3D-019E87A736CE
P2860
Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Preclinical restenosis models ...... mportant, still much to learn.
@ast
Preclinical restenosis models ...... mportant, still much to learn.
@en
type
label
Preclinical restenosis models ...... mportant, still much to learn.
@ast
Preclinical restenosis models ...... mportant, still much to learn.
@en
prefLabel
Preclinical restenosis models ...... mportant, still much to learn.
@ast
Preclinical restenosis models ...... mportant, still much to learn.
@en
P2093
P1476
Preclinical restenosis models ...... mportant, still much to learn.
@en
P2093
Nicolas A Chronos
Renu Virmani
Robert S Schwartz
P304
P356
10.1016/J.JACC.2004.04.060
P407
P577
2004-10-01T00:00:00Z